About Careers MedBlog Contact us

Research Leads to New Treatments for Young Patients With Crohn’s Disease

by Sheela Philomena on July 17, 2014 at 4:37 PM
Font : A-A+

 Research Leads to New Treatments for Young Patients With Crohn’s Disease

Bacteria and accompanying gene expression patterns in the small intestine affect course of irritable bowel disease (IBD) in children, finds research sponsored by the Crohn's & Colitis Foundation of America (CCFA).

The identification of specific bacterial populations and a core gene signature associated with Crohn's disease may also open the way to new molecular-level diagnostic tests, more relevant disease classification systems, and possibly even new treatment targets.  


"This study identifies a set of bacteria that are associated with symptoms, and a group of anti-inflammatory genes that are associated with intestinal damage in children with Crohn's disease," comments Lee A. Denson, MD, of Cincinnati Children's Hospital Medical Center.  The new findings—published online today by the Journal of Clinical Investigation—may lead to new approaches in the diagnosis, classification, and treatment of IBD.

In the CCFA-sponsored RISK study, researchers performed in-depth microbiological and gene expression studies in tissue samples (biopsies) from the ileum—the lowermost portion of the small intestine—in a large group of children with Crohn's disease.  The samples were obtained at the time of diagnosis and before the start of treatment.  The goal was to evaluate the bacteria and immune responses associated with IBD in children, and how these factors affect the course of the disease.

As in previous reports from the RISK study, there was a shift in the types of bacteria present in the ileum of children with newly diagnosed Crohn's disease.  Increases in certain types of bacteria and decreases in other types were strongly linked to the clinical severity of disease.

The researchers also identified a "core" gene expression signature in the ileum of children with Crohn's disease.  The genes involved have been linked to the inflammatory changes in the gut.  In addition, certain genes in the core signature appeared to be specifically associated with intestinal damage, in the form of deep ulcers.

"Both the levels of bacteria and the anti-inflammatory genes predicted the likelihood that a child would experience remission without needing steroids or surgery during the first year after diagnosis," according to Dr. Denson.  Information on the presence of these bacterial and gene expression factors improved accuracy in predicting the outcomes of treatment, compared to a conventional model based on clinical factors only. This information might help doctors in targeting patients who can benefit from more-intensive treatment for Crohn's disease—particularly as newer "biological" therapies for IBD become available.  The results also suggest that treatments to modify the bacterial population of the ileum may be necessary to achieve lasting clinical responses.

Research has shown that the way in which a person's body response to intestinal bacteria plays a role in the development of Crohn's disease.  The RISK study seeks to supply direct evidence for these interactions at the onset of IBD and is collaborating with CCFA's Microbiome and Genetics Initiatives:  two major research programs attempting to understand the interrelated microbial and genetic factors involved in IBD.   

Crohn's disease and ulcerative colitis are painful, medically incurable illnesses that attack the digestive system. Crohn's disease may attack anywhere along the digestive tract, while ulcerative colitis inflames only the large intestine (colon). Symptoms may include abdominal pain, persistent diarrhea, rectal bleeding, fever, fatigue and weight loss. Many patients require hospitalization and surgery. These illnesses can cause severe complications, including colon cancer in patients with long-term disease. Some 1.4 million American adults and children suffer from Crohn's disease or ulcerative colitis.

Reference: Crohn's & Colitis Foundation of America

Source: Medindia


Recommended Reading

Latest Child Health News

Elevated Hair Cortisol Levels in Newborns Cause Sleep Difficulties
Sleep patterns of infants can be anticipated based on cortisol levels during the later stages of pregnancy, says a new study to be presented at the annual meeting of SLEEP 2023.
 Baby Talk: How Boy and Girl Babies' Speech Differ During Infancy
Analyzing the earliest sex differences in language-related activities, recent research showed boys produced significantly more speech-like vocalizations (protophones) than girls.
Children Don't Always Outgrow Stuttering, but Speech Therapy can be Beneficial
A mother found a team at Saint Louis University's Speech-Language and Hearing Clinic that empowered her daughter to communicate with increased confidence in different settings.
Stunted Growth in North Korean Kids: What You Need to Know
In 2022, the number of North Korean kids falling under the obese category stood at 47,500 compared with 25,100 in 2012.
Fatty Acid in Breast Milk Linked to Improved Heart Function
In mice the maternal milk provides a key signal that instructs cardiomyocytes to activate lipid metabolism.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Research Leads to New Treatments for Young Patients With Crohn’s Disease Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests